X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (719) 719
Patent (22) 22
Magazine Article (15) 15
Newspaper Article (6) 6
Book Chapter (4) 4
Book / eBook (3) 3
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (417) 417
life sciences & biomedicine (403) 403
humans (402) 402
male (252) 252
female (237) 237
middle aged (218) 218
adult (207) 207
gastroenterology & hepatology (201) 201
antiviral agents - therapeutic use (136) 136
hepatitis c virus (134) 134
hepatitis c (124) 124
aged (115) 115
hepatitis c, chronic - drug therapy (108) 108
life sciences (98) 98
hepatitis (93) 93
infectious diseases (92) 92
treatment outcome (89) 89
immunology (84) 84
hepacivirus - genetics (82) 82
drug therapy, combination (76) 76
health aspects (72) 72
genotype (70) 70
hiv infections - complications (70) 70
abridged index medicus (69) 69
interferon (64) 64
interferon-alpha - therapeutic use (64) 64
gastroenterology and hepatology (63) 63
infections (61) 61
liver (60) 60
cirrhosis (59) 59
ribavirin - therapeutic use (58) 58
virology (58) 58
hiv (57) 57
viral load (56) 56
hepatitis c, chronic - virology (55) 55
general & internal medicine (51) 51
medicine, general & internal (51) 51
hepatitis c, chronic - complications (50) 50
ribavirin (50) 50
care and treatment (49) 49
hepatitis c - complications (49) 49
patients (49) 49
antiviral agents (48) 48
antiviral agents - adverse effects (47) 47
hepatitis c - drug therapy (47) 47
liver cirrhosis (47) 47
hepatitis b (46) 46
retrospective studies (46) 46
prospective studies (45) 45
virus diseases (44) 44
hepatitis b virus (43) 43
hiv infections - drug therapy (41) 41
risk factors (41) 41
liver - pathology (40) 40
analysis (39) 39
drug therapy (39) 39
human health and pathology (39) 39
aids/hiv (38) 38
antiviral agents - administration & dosage (38) 38
liver cirrhosis - virology (38) 38
recombinant proteins (38) 38
young adult (38) 38
liver diseases (37) 37
polyethylene glycols - therapeutic use (37) 37
genetic aspects (36) 36
biopsy (35) 35
ribavirin - administration & dosage (35) 35
hepacivirus - drug effects (32) 32
hepacivirus - isolation & purification (32) 32
adolescent (31) 31
fibrosis (31) 31
rna, viral - blood (31) 31
viruses (31) 31
france (30) 30
microbiology (30) 30
digestive system diseases (29) 29
hepatocellular carcinoma (29) 29
chronic infection (28) 28
hepacivirus (28) 28
medical research (28) 28
genotype & phenotype (27) 27
human immunodeficiency virus--hiv (27) 27
biological response modifiers (26) 26
hepatitis b, chronic - drug therapy (26) 26
liver cancer (26) 26
hcv (25) 25
recombinant proteins - therapeutic use (25) 25
ribavirin - adverse effects (25) 25
clinical trials (24) 24
hepatology (24) 24
interferon-alpha - administration & dosage (24) 24
liver cirrhosis - pathology (24) 24
medicine, experimental (24) 24
multivariate analysis (24) 24
aged, 80 and over (23) 23
disease progression (23) 23
follow-up studies (23) 23
research (23) 23
transplantation (23) 23
hepatitis b virus - genetics (22) 22
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, pp. e37563 - e37563
... , Stanislas Ropert 1 , Michel Vidal 4 , Stanislas Pol 5 , Stanislas Chaussade 3 , Francois Goldwasser 1 Introduction Hepatocellular carcinoma (HCC) accounts... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Niacinamide - analogs & derivatives | Humans | Middle Aged | Liver Neoplasms - drug therapy | Pyridines - pharmacokinetics | Antineoplastic Agents - therapeutic use | Benzenesulfonates - therapeutic use | Phenylurea Compounds | Benzenesulfonates - adverse effects | Dose-Response Relationship, Drug | Sarcopenia - chemically induced | Benzenesulfonates - pharmacokinetics | Pyridines - adverse effects | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Liver Neoplasms - metabolism | Survival Analysis | Adult | Aged | Antineoplastic Agents - pharmacokinetics | Retrospective Studies | Carcinoma, Hepatocellular - metabolism | Pyridines - therapeutic use | Antimitotic agents | Medical research | Sarcopenia | Analysis | Diarrhea | Medicine, Experimental | Hepatoma | Antineoplastic agents | Liver cirrhosis | Nuclear magnetic resonance--NMR | Laboratories | Toxicity | Oncology | Hepatocellular carcinoma | Males | Body composition | Body mass index | Liver cancer | Angiogenesis | Toxicology | Computed tomography | Tomography | Nosocomial infections | Drug dosages | Teaching hospitals | Hypertension | Medical imaging | Pharmacology | Metabolism | Patients | Constraining | Feet | Musculoskeletal system | Clinical medicine | Pharmacokinetics | Tumors | Index Medicus | Nuclear magnetic resonance | NMR
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2016
Graphical abstract 
Gastroenterology and Hepatology
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2016
Journal Article
The Lancet (British edition), ISSN 0140-6736, 10/2015, Volume 386, Issue 10003, pp. 1537 - 1545
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2015, Volume 385, Issue 9986, pp. 2502 - 2509
Journal Article
The Lancet (British edition), ISSN 0140-6736, 03/2015, Volume 385, Issue 9973, pp. 1087 - 1097
Journal Article
The Lancet (British edition), ISSN 0140-6736, 11/2014, Volume 384, Issue 9954, pp. 1597 - 1605
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 04/2015, Volume 15, Issue 4, pp. 397 - 404
Journal Article